Session: VL
Valvular Heart Disease

Marius Harpa (University of Medicine and Pharmacy Targu Mures), Ionela Movileanu (University of Medicine and Pharmacy Targu Mures), Leslie Sierad (Aptus Bioreactors Inc), Ovidiu Cotoi (University of Medicine and Pharmacy Targu Mures), Horatiu Suciu (University of Medicine and Pharmacy Targu Mures), Terezia Preda (University of Medicine and Pharmacy Targu Mures), Dan Nistor (University of Medicine and Pharmacy Targu Mures), Klara Branzaniuc (University of Medicine and Pharmacy Targu Mures), Radu Deac (University of Medicine and Pharmacy Targu Mures), Simona Gurzu (University of Medicine and Pharmacy Targu Mures), Lucian Harceaga (University of Medicine and Pharmacy Targu Mures), Loredana Harpa (University of Medicine and Pharmacy Targu Mures), Peter Olah (University of Medicine and Pharmacy Targu Mures), Nicoleta Suciu (University of Medicine and Pharmacy Targu Mures), Carmen Sircuta (University of Medicine and Pharmacy Targu Mures), Aggie Simionescu (Clemson University), Michael Dandel (University of Medicine and Pharmacy Targu Mures), Dan Simionescu (Clemson University)

Fred Schoen (Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA), Marieke Brugmans (Xeltis BV, Eindhoven), Oleg Svanidze (Xeltis BV, Eindhoven), Martin Cox (Xeltis BV, Eindhoven)

Michael Sacks (University of Texas at Austin), Rachel Buchanan (University of Texas at Austin)